The FDA approved Scinopharm's glatiramer acetate injection, a generic version of Copaxone, to treat multiple sclerosis.
Tiziana's foralumab continues to be safe and well-tolerated, with no drug-related serious side effects after long-term use, ...
The FDA rejected Sanofi's MS drug tolebrutinib, citing liver injury risks, unclear benefits, and trial data that failed to ...
Exposure to common environmental chemicals, especially in combination, is linked to an increased risk of multiple sclerosis.
The Functional Outcomes from Diet in Multiple Sclerosis (FOOD for MS) study will test whether eating healthy foods and losing weight can improve physical function, pain, fatigue, mood, and sleep in ...
Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis Paris, December 24, 2025. The US Food and Drug Administration (FDA) has issued a ...
ScinoPharm Taiwan (TWSE: 1789) today announced a landmark achievement in the global pharmaceutical landscape, securing U.
AB Science SA (Euronext - FR0010557264 - AB) announced today that its Phase III clinical trial (AB20009) in progressive forms of multiple sclerosis has been approved by the US Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback